abstract |
Disclosed are cyclohexano- and cycloheptapyrazole derivative compounds or purified stereoisomers or stereoisomer mixtures of said compounds and their salts or prodrug forms thereof which have structural formulas (I), (Ia), (II) or (IIa): wherein the variables R, R1, R2, R3 and R4 are as defined in the specification. The compounds are useful for the treatment or prevention of diseases and/or behaviors involving the 5-HT2C receptor. |